Why the study?
What are the outcomes and predictors of complications in the percutaneous management of iatrogenic cardiac perforation due to pacemaker and defibrillator leads?
Design
Multicentre study
Authors
Loading...
Supports percutaneous management of rare lead perforations; leaves open prospective validation of anticoagulation-guided risk reduction.
What are the outcomes and predictors of complications in the percutaneous management of iatrogenic cardiac perforation due to pacemaker and defibrillator leads?
Iatrogenic cardiac perforation from device leads is a rare complication (0.50%) that can be successfully managed percutaneously, though baseline anticoagulation increases the risk of tamponade.
Waddingham et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: